Day 2 - EST/EDT (Eastern Daylight, GMT-4)
Day 2 - EST/EDT (Eastern Daylight, GMT-4)
- Jeffrey Baker - Senior Fellow, NIIMBL; Strategic Advisor, CBI-MIT
- Nadine Ritter, Ph.D. - President and Analytical Advisor, Global Biotech Experts, LLC
- Johnson Varghese - Vice President, Head of Analytical Sciences & Development, Beam Therapeutics
In recent years we have learned that Host Cell Proteins (HCP) can cause problems with respect to patient safety, Drug Substance (DS) stability, and DS efficacy. As such, it is more important than ever to fully understand the HCPs in your process. This talk will focus on using advanced methods of immunoaffinity chromatography and mass spectrometry to fully characterize the Host Cell Protein ELISA as well as the individual HCPs in in-process and DS samples.
- Eric Bishop - Vice President of Research & Development, Cygnus Technologies
- Kristen Nields - Senior Scientist, The Janssen Pharmaceutical Companies of Johnson & Johnson
- Yi Yang, Ph.D. - Senior Scientist, Protein Chemistry Group, Genentech Inc
- Jason Rouse, Ph.D. - Senior Director, Pfizer, Inc.
- Jeffrey Baker - Senior Fellow, NIIMBL; Strategic Advisor, CBI-MIT
- Nadine Ritter, Ph.D. - President and Analytical Advisor, Global Biotech Experts, LLC
- Johnson Varghese - Vice President, Head of Analytical Sciences & Development, Beam Therapeutics
- Lorena Lopez - LC Applications Scientist, Agilent
- Jessica Hung - Principal Scientist, Bristol Myers Squibb
- Nicole Ferreira - Associate Principal Scientist, Chemistry, Merck
- Jan Verelst - Global Business Development Manager SIPAT, Siemens
- Jason Rouse, Ph.D. - Senior Director, Pfizer, Inc.
- Aaron Morgan - Director of QC Analytical, Wheeler Bio
- Joe Cintavey - Product Specialist, Gore & Associates
- Neeraj Agrawal - Director, Amgen
- Sethu Alexander - Associate Director, Analytical Development-VRA, Takeda Pharmaceuticals
- Dhanuka Wasalathanthri, PhD - Senior Principal Scientist, Bristol Myers Squibb
- Lunedt Gonzalez-Pepe - Scientist I, Alexion Pharmaceuticals, AstraZeneca Rare Disease Unit
- Neeraj Agrawal - Director, Amgen
- Louisa Maitland - Festival Director, Informa Connect
- Anne Montgomery - Editor in Chief, BioProcess International Magazine, Informa
Every successful leader must know what they are fighting for—and to know that whatever “it” is that you’re fighting for, it’s bigger than you and bigger than all of us. John F. Crowley believes leading with passion and compassion is exactly what the biotech industry needs today. John will share his entrepreneurial journey that led him to success at multiple biotech companies, how the rare disease community, including two of his children who have Pompe disease, are the reason he continues to fight and actionable tips for leaders shaping the future of biotech.
- John Crowley - Executive Chairman, Amicus Therapeutics